Previous Page  8 / 10 Next Page
Information
Show Menu
Previous Page 8 / 10 Next Page
Page Background

Page 45

June 10-11, 2019 | Edinburgh, Scotland

Central Nervous System and Therapeutics

2

nd

International Conference on

Journal of Neurology and Neurorehabilitation Research | Volume 4

allied

academies

Omega-3 Fatty Acids: A novel approach for pain treatment

Carlos Laino

National University of La Rioja, Argentina

T

he treatment of acute and chronic severe pain remains an

important common challenge faced by clinicians working

with the general population, and even after applying recent

advances in the treatment of acute and chronic severe pain,

there can continue to be manifestations of adverse effects.

Chronic pain affects many aspects in the life of the patient,

and often has an impact on their families. In some cases,

after an acute pain, the patient continues to experience

chronic pain, which can be a result of illnesses such as cancer.

As there is growing evidence that omega-3 fatty acids can

contribute to the reduction of pain, this presentation will

describe an innovative technological development, both in its

pharmaceutical composition (using omega-3 fatty acids with

either morphine or methadone) and in the pharmacological

treatments associated with its use. In addition, the preclinical

evidence concerning the analgesic effects of omega-3 fatty

acids (eicosapentaenoic acid and docosahexaenoic acid) will

also be explored.

The main advantage of new pharmacological treatments

using these pharmaceutical compositions lies in the improved

pain control obtained with a sub-therapeutic dose of these

opioids, which can lead to the elimination or at least potential

reduction of the adverse effects.

e

:carloslaino25@gmail.com

Notes: